TREVI
Live / Applied — Second extension granted (statement of use) (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 20 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98324669
- Mark type
- Stylized text
- Filed
- 20 Dec 2023
- Published for opposition
- 10 Sept 2024
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pulmonary, respiratory, fibrotic, dermatologic conditions, diseases, and disorders; Pharmaceutical preparations for the treatment of chronic cough and hypersensitivity disorders
Owner
- Trevi Therapeutics, Inc., New Haven, CT, US
- Trevi Therapeutics, Inc., New Haven, CT, US
Prior registrations
Prosecution history
- 05 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2025 — SOU EXTENSION 2 GRANTED
- 04 Nov 2025 — SOU EXTENSION 2 FILED
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2025 — SOU EXTENSION 1 GRANTED
- 04 Apr 2025 — SOU EXTENSION 1 FILED
- 04 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2025 — ASSIGNED TO EXAMINER
- 05 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jul 2024 — ASSIGNED TO EXAMINER